CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $754,917 | -66.7% | 64,578 | -47.0% | 0.00% | -83.3% |
| Q4 2022 | $2,266,838 | +163.6% | 121,873 | -0.6% | 0.01% | +100.0% |
| Q2 2022 | $860,000 | -32.5% | 122,638 | -20.2% | 0.01% | -45.5% |
| Q1 2022 | $1,274,000 | +5.6% | 153,709 | -13.8% | 0.01% | +22.2% |
| Q4 2021 | $1,207,000 | +169.4% | 178,320 | +111.0% | 0.01% | +50.0% |
| Q3 2021 | $448,000 | +75.7% | 84,502 | +90.9% | 0.01% | +100.0% |
| Q2 2021 | $255,000 | +94.7% | 44,264 | +30.1% | 0.00% | -40.0% |
| Q1 2020 | $131,000 | – | 34,024 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,378,584 | $3,116,000 | 2.30% |
| TANAKA CAPITAL MANAGEMENT INC | 147,993 | $298,000 | 0.90% |
| SOPHROSYNE CAPITAL LLC | 282,500 | $638,000 | 0.56% |
| Ghost Tree Capital, LLC | 200,000 | $452,000 | 0.27% |
| Orbimed Advisors | 1,895,000 | $4,283,000 | 0.05% |
| Financial Architects, Inc | 30,000 | $68,000 | 0.04% |
| Cowen Prime Services LLC | 43,550 | $98,000 | 0.04% |
| Rotella Capital Management, Inc. | 12,300 | $28,000 | 0.03% |
| FEDERATED HERMES, INC. | 3,267,000 | $7,384,000 | 0.02% |
| Baker Brothers Advisors | 569,853 | $1,288,000 | 0.02% |